Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) Return on equity
Hinge Health Inc.'s return on equity over the twelve months to 30 June 2026 was 41.4%, down 290.0 percentage points from fiscal 2025 (331.4%). That is above the Health Information Services industry median of −3.15% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 331.4% | 328.66 |
| FY2024 | 2.78% | 2.78 |
| FY2023 | 0.00% | — |
Return on equity against peers
| Company | Return on equity |
|---|---|
| HNGE Hinge Health Inc. | 41.4% |
| HTFL Heartflow, Inc. compare | 38.5% |
| BTSG BrightSpring Health Services, Inc. compare | 20.5% |
| DOCS Doximity, Inc. compare | 13.8% |
| HQY HealthEquity, Inc. compare | 11.4% |
| PRVA Privia Health Group, Inc. compare | 4.25% |
| WAY Waystar Holding Corp. compare | 3.72% |
| SDGR Schrodinger, Inc. compare | −19.0% |
| TEM Tempus AI, Inc. compare | −37.6% |
| Health Information Services industry median | −3.15% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on HNGE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement